Does sublingual semaglutide or tirzepatide actually work?

The question deserves a more honest answer than either the marketing (“needle-free Wegovy!”) or the dismissal (“it’s fake”) you’ll find elsewhere. The case that it works: semaglutide is the same molecule regardless of route; if enough reaches the bloodstream, receptors don’t care how it arrived. Oral-mucosa delivery is established for other drugs, prescribers in this space report visible appetite suppression and weight loss in many sublingual patients, and the higher milligram ladders are designed to compensate for lower absorption. The case for skepticism: peptides are large, fragile molecules that the mouth’s lining absorbs inefficiently — unenhanced sublingual bioavailability of peptides is typically low single-digit percent, and it varies with formulation, contact time, saliva, and technique. No randomized controlled trial has measured sublingual semaglutide or tirzepatide weight loss. That means average results, variability, and optimal dosing are genuinely unknown — and pharmacy formulation quality becomes the hidden variable. The practical resolution: treat sublingual therapy as an experiment with your own data. Hold technique constant (dissolve fully under the tongue; no food, drink, or smoking for ≈15 minutes after). Track weight and appetite weekly. By weeks 8–12 on a meaningful dose you should see clear appetite change and steady loss; if not, the absorption isn’t happening for you — switch to injections or an oral option rather than escalating indefinitely. And source only from programs using licensed compounding pharmacies.